STOCK TITAN

[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Hims & Hers Health (HIMS) disclosed an insider transaction by its Chief Legal Officer. On 10/13/2025, the officer sold 2,637 shares of Class A common stock at $54.38 per share (Transaction Code S) and held 161,130 shares directly after the sale. The sales were effected under a Rule 10b5-1 trading plan adopted on August 28, 2024.

Hims & Hers Health (HIMS) ha comunicato una transazione interna da parte del suo Chief Legal Officer. Il 13/10/2025, il dirigente ha venduto 2.637 azioni ordinarie di Classe A a 54,38 dollari per azione (Codice di transazione S) e deteneva direttamente 161.130 azioni subito dopo la vendita. Le vendite sono state effettuate nell'ambito di un piano di trading Rule 10b5-1 adottato il 28 agosto 2024.

Hims & Hers Health (HIMS) divulgó una operación interna de su Director Jurídico. El 13/10/2025, el directivo vendió 2.637 acciones ordinarias Clase A a 54,38 dólares por acción (Código de operación S) y poseía 161.130 acciones directamente después de la venta. Las ventas se realizaron bajo un plan de negociación Rule 10b5-1 adoptado el 28 de agosto de 2024.

Hims & Hers Health (HIMS)가 최고 법무 책임자의 내부 거래를 공개했습니다. 2025년 10월 13일 그 임원은 클래스 A 보통주를 주당 54.38달러에 2,637주 매도했고, 매도 직후 직접 보유 주식은 161,130주였습니다. 매도는 2024년 8월 28일에 채택된 Rule 10b5-1 거래 계획에 따라 이루어졌습니다.

Hims & Hers Health (HIMS) a divulgué une opération interne de son directeur juridique. Le 13/10/2025, le cadre a vendu 2 637 actions ordinaires de classe A à 54,38 $ par action (code de transaction S) et détenait 161 130 actions directement après la vente. Les ventes ont été réalisées dans le cadre d'un plan de trading Rule 10b5-1 adopté le 28 août 2024.

Hims & Hers Health (HIMS) hat eine Insider-Transaktion seines Chief Legal Officers bekannt gegeben. Am 13.10.2025 verkaufte der Beamte 2.637 Aktien der Class-A-Stammaktie zu 54,38 $ pro Aktie (Transaktionscode S) und hielt nach dem Verkauf direkt 161.130 Aktien. Die Verkäufe erfolgten im Rahmen eines Rule-10b5-1-Handelsplans, der am 28. August 2024 verabschiedet wurde.

Hims & Hers Health (HIMS) أبلغت عن صفقة داخلية من قبل كبير مسؤولي الشؤون القانونية لديها. في 13/10/2025 باع المسؤول 2,637 سهماً من الأسهم العادية من الفئة أ بسعر 54.38 دولاراً للسهم (رمز الصفقة S) وكان يمتلك 161,130 سهماً مباشرة بعد البيع. تمت عمليات البيع بموجب خطة تداول Rule 10b5-1 التي تم اعتمادها في 28 أغسطس 2024.

Hims & Hers Health (HIMS) 披露其首席法务官的内幕交易。2025年10月13日,该官员以每股54.38美元的价格出售了2,637股A类普通股,交易代码为S,出售后直接持有161,130股。此次出售是在2024年8月28日通过的Rule 10b5-1交易计划下进行的。

Positive
  • None.
Negative
  • None.

Hims & Hers Health (HIMS) ha comunicato una transazione interna da parte del suo Chief Legal Officer. Il 13/10/2025, il dirigente ha venduto 2.637 azioni ordinarie di Classe A a 54,38 dollari per azione (Codice di transazione S) e deteneva direttamente 161.130 azioni subito dopo la vendita. Le vendite sono state effettuate nell'ambito di un piano di trading Rule 10b5-1 adottato il 28 agosto 2024.

Hims & Hers Health (HIMS) divulgó una operación interna de su Director Jurídico. El 13/10/2025, el directivo vendió 2.637 acciones ordinarias Clase A a 54,38 dólares por acción (Código de operación S) y poseía 161.130 acciones directamente después de la venta. Las ventas se realizaron bajo un plan de negociación Rule 10b5-1 adoptado el 28 de agosto de 2024.

Hims & Hers Health (HIMS)가 최고 법무 책임자의 내부 거래를 공개했습니다. 2025년 10월 13일 그 임원은 클래스 A 보통주를 주당 54.38달러에 2,637주 매도했고, 매도 직후 직접 보유 주식은 161,130주였습니다. 매도는 2024년 8월 28일에 채택된 Rule 10b5-1 거래 계획에 따라 이루어졌습니다.

Hims & Hers Health (HIMS) a divulgué une opération interne de son directeur juridique. Le 13/10/2025, le cadre a vendu 2 637 actions ordinaires de classe A à 54,38 $ par action (code de transaction S) et détenait 161 130 actions directement après la vente. Les ventes ont été réalisées dans le cadre d'un plan de trading Rule 10b5-1 adopté le 28 août 2024.

Hims & Hers Health (HIMS) hat eine Insider-Transaktion seines Chief Legal Officers bekannt gegeben. Am 13.10.2025 verkaufte der Beamte 2.637 Aktien der Class-A-Stammaktie zu 54,38 $ pro Aktie (Transaktionscode S) und hielt nach dem Verkauf direkt 161.130 Aktien. Die Verkäufe erfolgten im Rahmen eines Rule-10b5-1-Handelsplans, der am 28. August 2024 verabschiedet wurde.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Boughton Soleil

(Last) (First) (Middle)
2269 CHESTNUT STREET, #523

(Street)
SAN FRANCISCO CA 94123

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 10/13/2025 S(1) 2,637 D $54.38 161,130 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.
Remarks:
/s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton 10/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did HIMS report?

The Chief Legal Officer sold 2,637 Class A shares on 10/13/2025 at $54.38 per share (Code S).

Who was the reporting person in the HIMS Form 4?

The reporting person is an officer, serving as Chief Legal Officer.

How many HIMS shares remained after the transaction?

Following the sale, the officer directly owned 161,130 shares.

Was the HIMS sale under a 10b5-1 plan?

Yes. The sales were effected under a Rule 10b5-1 trading plan adopted on August 28, 2024.

What security class was involved in the HIMS insider sale?

The transaction involved Class A common stock.

What was the transaction code on the HIMS Form 4?

The sale is reported with transaction code S.
Hims & Hers Health Inc

NYSE:HIMS

HIMS Rankings

HIMS Latest News

HIMS Latest SEC Filings

HIMS Stock Data

12.21B
202.99M
10.63%
88.99%
33.02%
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
Link
United States
SAN FRANCISCO